1. Home
  2. CYCN vs UGRO Comparison

CYCN vs UGRO Comparison

Compare CYCN & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

N/A

Current Price

$1.47

Market Cap

5.7M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$22.81

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCN
UGRO
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
13.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CYCN
UGRO
Price
$1.47
$22.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.9K
10.2M
Earning Date
05-05-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.11
52 Week High
$3.79
$39.68

Technical Indicators

Market Signals
Indicator
CYCN
UGRO
Relative Strength Index (RSI) 49.36 67.77
Support Level $1.31 $0.71
Resistance Level $1.63 N/A
Average True Range (ATR) 0.10 6.25
MACD -0.01 2.01
Stochastic Oscillator 41.10 53.69

Price Performance

Historical Comparison
CYCN
UGRO

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: